Skip to main content
Fig. 5 | Respiratory Research

Fig. 5

From: Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial

Fig. 5

a Heat map and b biochemical pathway for complex lipids. DAG, diacylglycerol; FF/VI, fluticasone furoate/vilanterol trifenatate; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PLA2, phospholipase A2; TAG, triacylglycerol; T1, baseline; T2, Day 15; T3, Day 21

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us